Over patients
have been prescribed VYALEV globally†
More “On” time is possible with VYALEV*
*VYALEV was studied against oral immediate-release carbidopa/levodopa pills. At week 12, patients taking VYALEV achieved 2.72 hours more “On” time vs 0.97 hours more “On” time for those taking levodopa pills, a difference of 1.75 hours.
†Based on total patient numbers as of April 2026. Product name and use differ by country.
Control
of motor fluctuations with almost 2 hours more "On" time per day without troublesome dyskinesia than treatment with pills alone||
‡Delivered under the skin through a wearable pump. No surgery required.
§VYALEV replaces levodopa-containing medications and COMT inhibitors. Ask your doctor about the right VYALEV dose for you. Keep a supply of oral immediate-release carbidopa/levodopa pills with you in case you are unable to use VYALEV infusion.
||VYALEV was studied against oral immediate-release carbidopa/levodopa pills. At week 12, patients taking VYALEV achieved 2.72 hours more “On” time vs 0.97 hours more “On” time for those taking levodopa pills, difference of 1.75 hours.
Dyskinesia: Bothersome extra movements you don't have control over.
COMT=catechol-O-methyltransferase.
Designed for people with Parkinson’s disease
VYALEV is a levodopa-based therapy delivered just under the skin through a wearable pump. Hear certified nurse practitioner Shannon Shaffer explain how VYALEV works, and how it may help people living with advanced Parkinson's disease.
What real VYALEV patients have said
according to patient survey data:
&
94% of patients would recommend VYALEV to others¶
¶Based on a 2026 survey of 78 people who had been using VYALEV for at least 3 months. People rated their level of agreement from 1 (strongly disagree) to 7 (strongly agree). Ratings of 5 to 7 were considered agreement.